How to Prevent Postherpetic Neuralgia: Vaccines and Antivirals

The single most effective way to prevent postherpetic neuralgia is to avoid getting shingles in the first place, which means vaccination. If you already have shingles, starting antiviral treatment quickly is your best option for reducing the risk of lingering nerve pain. Postherpetic neuralgia (PHN) is defined as pain lasting three months or more after the shingles rash has healed, and it can persist for months or even years.

Vaccination Is the Strongest Protection

Shingrix, the recombinant shingles vaccine, is the most reliable way to prevent both shingles and PHN. It’s recommended as two doses for adults 50 and older, spaced two to six months apart. There is no maximum age for getting it. For adults 19 and older with weakened immune systems due to disease or immunosuppressive therapy, the CDC also recommends two doses, which can be given as close as one to two months apart if needed.

If you’re on medications that suppress your immune system (such as anti-B cell therapies), the timing matters. Ideally, you’d receive a dose about four weeks before your next scheduled treatment to give your body a better chance to build immunity. Shingrix is not a treatment for active shingles or existing PHN, so the time to get vaccinated is before an outbreak occurs.

Even people who have already had shingles can and should get vaccinated, because the virus can reactivate more than once. Vaccination after a previous episode reduces the odds of a repeat outbreak and, by extension, lowers the chance of developing PHN the next time around.

Early Antiviral Treatment During Shingles

If you develop shingles, the most important thing you can do is get antiviral medication as soon as possible. Guidelines recommend starting antivirals within 72 hours of rash onset, particularly for anyone 50 or older, anyone with a weakened immune system, and anyone with moderate to severe pain or a rash on the face or other non-trunk areas. Treatment can still be considered up to seven days after the rash appears, especially if new blisters are still forming, pain is severe, or you’re older or immunocompromised.

Antivirals accelerate rash healing and limit the severity and duration of acute pain. There is also some evidence they reduce the risk of PHN, likely by limiting the nerve damage the virus causes during reactivation. That said, the evidence for PHN prevention specifically is not as strong as many people assume. The benefit appears to be most meaningful when treatment starts early and in patients at higher risk.

About 65% of adults with shingles see a doctor within 72 hours, but roughly 7% don’t seek care until after the seven-day window, at which point antivirals are less useful. Recognizing shingles early, a painful, blistering rash typically on one side of the body, is key to acting within that treatment window.

What Doesn’t Work

Several treatments that seem like logical candidates for preventing PHN have been tested and found ineffective. Oral corticosteroids given during acute shingles do not reliably prevent PHN. A Cochrane review of the available evidence concluded that corticosteroids neither support nor refute prevention of postherpetic neuralgia, with very low certainty in the data.

Medications commonly used to treat nerve pain, including gabapentinoids and duloxetine, have also been studied as preventive treatments during the acute shingles phase. None have been shown to reduce the rate of PHN when started early. This is a meaningful distinction: these drugs can help manage PHN symptoms once they develop, but taking them during shingles does not appear to stop PHN from setting in.

Who Is Most at Risk for PHN

Understanding your risk profile helps you know how aggressively to pursue prevention. A large meta-analysis published in Frontiers in Immunology identified several independent risk factors for developing PHN:

  • Age 60 or older. Risk increases meaningfully with age and is one of the strongest predictors.
  • Severe rash. More extensive skin involvement and more severe blistering raise the odds of PHN by roughly 50%.
  • Intense acute pain. People with moderate to severe pain during shingles had about 2.5 times the risk of developing PHN compared to those with mild pain.
  • Pain that persists after the rash clears. Ongoing pain after the rash phase doubled the likelihood of PHN.
  • Immunosuppression. Whether from medication or disease, a weakened immune system makes PHN more likely.
  • Smoking and alcohol abuse. Both are independently associated with higher PHN rates.
  • Chronic conditions. Diabetes, COPD, hypertension, chronic kidney disease, and cancer all increase risk.

If you fall into multiple categories, the case for vaccination is especially strong, and seeking treatment immediately at the first sign of shingles becomes even more critical.

Shingles Without a Rash

In rare cases, the varicella-zoster virus reactivates without producing a visible rash, a condition called zoster sine herpete. This happens when the virus reactivates in nerves that don’t project to the skin, such as those in the gut or autonomic nervous system. The result is nerve pain without the telltale blisters, which makes diagnosis difficult and often delays treatment.

That delay matters. Without timely antivirals, the virus can cause significant nerve damage, leading to prolonged neuralgia and potentially PHN. Shingrix vaccination should reduce the risk of this atypical presentation just as it does for standard shingles. If you experience unexplained, persistent nerve pain on one side of the body, especially if you’re over 50 or immunocompromised, it’s worth raising the possibility of zoster sine herpete with your doctor.

A Practical Prevention Timeline

Prevention happens in stages. Before shingles, get vaccinated with Shingrix if you’re eligible. This is the highest-impact step. During shingles, start antiviral treatment as early as possible, ideally within 72 hours of the rash appearing. If you’re in a high-risk group and it’s been up to seven days, treatment may still be worthwhile. After shingles, if pain persists as the rash heals, work with your doctor on managing that pain promptly. While no specific medication has been proven to prevent the transition from acute pain to PHN, controlling pain early may reduce the overall burden and duration of symptoms.

The factors you can control come down to three things: getting vaccinated before shingles strikes, acting fast if it does, and managing modifiable risk factors like smoking. For a condition that can cause burning, stabbing pain lasting months or years, these steps are well worth the effort.